Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 7, 2021; 27(25): 3851-3862
Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3851
Published online Jul 7, 2021. doi: 10.3748/wjg.v27.i25.3851
Figure 7 Zinc oxide nanoparticle reduces the tumor growth of chemoresistant gastric cancer cells in vivo.
The impact of zinc oxide nanoparticle (ZnO-NP) on tumor growth of cisplatin (DDP)-resistant gastric cells in vivo was analyzed by the nude mice tumorigenicity assay (n = 5). SGC7901/DDP cells were treated with ZnO-NP (5 μg/mL) or an equal volume of saline. A: Representative images of dissected tumors from nude mice are shown; B: The average tumor volume was calculated; C: The average tumor weight was calculated. Data are presented as the mean ± SD. Statistic significant differences are indicated: bP < 0.01.
- Citation: Miao YH, Mao LP, Cai XJ, Mo XY, Zhu QQ, Yang FT, Wang MH. Zinc oxide nanoparticles reduce the chemoresistance of gastric cancer by inhibiting autophagy. World J Gastroenterol 2021; 27(25): 3851-3862
- URL: https://www.wjgnet.com/1007-9327/full/v27/i25/3851.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i25.3851